Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
227
datasets available to search
ShareScore release 0.7.1
Dataset results
227 results for “CVD”
Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry
Open the record for dataset details and reuse information.
Improved route to a diphenoxide-based precursor for CVD of parylene AF-4
In this work, we present an easy synthesis of a alternative precursor for CVD of parylene AF-4 to the widely used standard, Octafluoro[2.2]paracyclophane. The standard precursor suffers from uncertainties in its supply chain and its synthesis is of low yield. A comparison between different reaction parameters and solvents are being discussed by means of thermal, laboratory scale and microwave assisted reactions and qNMR studies.
IDSL.UFA results for THSTI-CVD study (ST002044)
<p>Serum samples from CVD patients in the Safdarganj Hospital New Delhi were analyzed for untargeted metabolomics using a Thermo Fusion instrument by the THSTI metabolomics facility. Raw data were processed using the IDSL.IPA and IDSL.UFA software for the annotation of molecular formula. </p>
Comparative Study of Field-Effect Transistors Based on Graphene Oxide and CVD Graphene in Highly Sensitive NT-proBNP Aptasensors
<p>Graphene-based materials are actively being investigated as sensing elements for the detection of different analytes. Both graphene grown by chemical vapor deposition (CVD) and graphene oxide (GO) produced by the modified Hummers’ method are actively used in the development of biosensors. The production costs of CVD graphene- and GO-based sensors are similar; however, the question remains regarding the most efficient graphene-based material for the construction of point-of-care diagnostic devices. To this end, in this work, we compare CVD graphene aptasensors with the aptasensors based on reduced GO (rGO) for their capabilities in the detection of NT-proBNP, which serves as the gold standard biomarker for heart failure. Both types of aptasensors were developed using commercial gold interdigitated electrodes (IDEs) with either CVD graphene or GO formed on top as a channel of liquid-gated field-effect transistor (FET), yielding GFET and rGO-FET sensors, respectively. The functional properties of the two types of aptasensors were compared. Both demonstrate good dynamic range from 10 fg/mL to 100 pg/mL. The limit of detection for NT-proBNP in artificial saliva was 100 fg/mL and 1 pg/mL for rGO-FET- and GFET-based aptasensors, respectively. While CVD GFET demonstrates less variations in parameters, higher sensitivity was demonstrated by the rGO-FET due to its higher roughness and larger bandgap. The demonstrated low cost and scalability of technology for both types of graphene-based aptasensors may be applicable for the development of different graphene-based biosensors for rapid, stable, on-site, and highly sensitive detection of diverse biochemical markers.</p>
The Effect of C60 and Pentacene Adsorbates on the Electrical Properties of CVD Graphene on SiO2 (Dataset)
<p>Dataset of the GFETs measurements related to the publication: "The Effect of C60 and Pentacene Adsorbates on the Electrical Properties of CVD Graphene on SiO2", MDPI, Nanomaterials, 2023.</p> <p>The dataset includes:</p> <ol> <li>AFM raw data</li> <li>Raman spectroscopy raw data</li> <li>GFETs IV and gate sweep raw data</li> </ol>
Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics
ClinicalTrials.gov study NCT02299791. IPD Sharing: NO. Countries: 0. Publications: 4.
Socioeconomic Status, Psychosocial Factors, and CVD Risk in Mexican-American Women
ClinicalTrials.gov study NCT00387166. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Optimizing the Impact of the Healthy School Recognized Campus Program on Youth's CVD Risk Factors
ClinicalTrials.gov study NCT05977959. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators
ClinicalTrials.gov study NCT01610661. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)
ClinicalTrials.gov study NCT01692574. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients
ClinicalTrials.gov study NCT02763943. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Association Between Inflammatory Biomarkers in CVD Patients on Empagliflozin.
ClinicalTrials.gov study NCT05911724. IPD Sharing: NO. Countries: 1. Publications: 6.
WISE CVD - Continuation (WISE HFpEF)
ClinicalTrials.gov study NCT02582021. IPD Sharing: YES. Countries: 1. Publications: 4.
A Study Into the Future Cardiovascular Disease (CVD) Risk of Phenylketonuria (PKU) Patients on a Low Phenylalanine Treatment Diet (LPD).
ClinicalTrials.gov study NCT04251494. IPD Sharing: NO. Countries: 1. Publications: 5.
Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction
ClinicalTrials.gov study NCT04798430. IPD Sharing: NO. Countries: 6. Publications: 0.
MySlainte: Testing the Effect of Involving Partners in a CVD Prevention Community Lifestyle Program
ClinicalTrials.gov study NCT04300465. IPD Sharing: NO. Countries: 1. Publications: 1.
Quinoa Biscuit & CVD Risk Trial
ClinicalTrials.gov study NCT03291548. IPD Sharing: NO. Countries: 1. Publications: 1.
Prevention of NAFLD and CVD Through Lifestyle Intervention
ClinicalTrials.gov study NCT05618626. IPD Sharing: NO. Countries: 1. Publications: 101.
Pharmacist CVD Intervention for Patients With Inflammatory Arthritis
ClinicalTrials.gov study NCT03152396. IPD Sharing: NO. Countries: 1. Publications: 1.
Impact of GBS on CVD in Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00787670. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.